Leishmaniasis Therapy
Research from College of Medicine, Department of Dermatology in the area of leishmaniasis therapy described
Published in TB and Outbreaks Week, March 30th, 2010
A new study, 'Evaluation of intralesional 0.2% ciprofloxacin as a treatment for cutaneous leishmaniasis,' is now available. "Although cutaneous leishmaniasis lesions usually heal spontaneously they cause unsightly scarring. This study evaluated a possible new therapy in 38 patients, with 70 lesions, randomly assigned to intralesional injection of ciprofloxacin (0.2%) or intralesional sodium chloride hypertonic solution (7%)," scientists writing in the Eastern Mediterranean Health Journal = La Revue De Sante De La Mediterranee Orientale report.
"After excluding patients who defaulted on treatment, lesions assigned to sodium chloride treatment (n=21) were...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- American Thoracic Society
New TB booster shows promise - Society of Critical Care Medicine
Children with chronic respiratory illness are vulnerable to critical H1N1 - University of Utah Health Sciences
Targeting blood vessels, immune system may offer way to stop infection-caused inflammation - Abscess
Reports by S. Mascarenhas and co-researchers describe recent advances in abscess - AuthorHouse
'Overlooked Causes and the Prevention: Cancer, Cardiovascular Heart Disease, Multiple Sclerosis': New Health Book Examines Three Major Chronic Diseases - BioSense Technologies
BioSense Technologies' Novel Diagnostic Testing Platform for Rapid Drug Susceptibility Presented at the National Foundation for Infectious Disease 2010 Annual Conference - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
